A rare association of systemic sclerosis with psoriasis vulgaris

Journal of Dermatology

Volumn 27, Issue 5, 2000, Pages 346-349

  Yamamoto, Toshiyuki ^b   Katayama, Ichiro ^a,b   Nishioka, Kiyoshi ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Psoriasis; Scleroderma

Indexed keywords

PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYALGIA; ONSET AGE; PSORIASIS VULGARIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

EID: 0033946777     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2000.tb02180.x     Document Type: Article

References (15)

1. Krieg T, Meurer M: Systemic sclerosis. Clinical and pathophysiologic aspects, J Am Acad Dermatol, 18: 457-481, 1998.
2. LeRoy EC, Black C, Fleischmajer R, et al: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis, J Rheumatol, 15: 202-205, 1988.
3. Kahaleh B: Lymphocyte interactions with the vascular endothelium in systemic sclerosis, Clin Dermatol, 12: 361-367, 1994.
4. Arbiser JL: Angiogenesis and the skin: A primer, J Am Acad Dermatol, 34: 486-497, 1996.
5. Lynch WS, Roenigk HH Jr: Lupus erythematosus and psoriasis vulgaris, Cutis, 21: 511-525, 1978.
6. Millns JR, Muller SA: The coexistence of psoriasis and lupus erythematosus, Arch Dermatol, 116: 658-663, 1980.
7. Kulick KB, Mogavero H Jr, Provost TT, Reichlin M: Serologic studies in patients with lupus erythematosus and psoriasis, J Am Acad Dermatol, 8: 631-634, 1983.
8. Hays SB, Camisa C, Luzar MJ: The coexistence of systemic lupus erythematosus and psoriasis, J Am Acad Dermatol, 10: 619-622, 1984.
9. Fine RM: Psoriasis and autoimmune disease, Int J Dermatol, 27: 17-18, 1988.
10. Nestle FO, Turka LA, Nickoloff Bf: Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines, J Clin Invest, 94: 202-209, 1994.
11. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol, 101: 701-705, 1993.
12. Gomi T, Shiohara T, Munakata T, Imanishi K, Nagashima M: Interleukin-1α, tumor necrosis factor α, and interferon γ in psoriasis, Arch Dermatol, 127: 827-830, 1991.
13. Duncan MR, Bermann B: γ-interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation, J Exp Med, 162: 516-527, 1985.
14. Castells-Rodellsa A, Castell JV, Ramirez-Bosca A, Nicolas JF, Valcuende-Cvavero F, Thivolet J: Interleukin-6 in normal skin and psoriasis, Acta Derm Venereol (Stockh), 72: 165-168, 1992.
15. Romagnani S: TH1 and TH2 in human diseases, Clin Immunol Immunopathol, 80: 225-235, 1996.